BioCentury
ARTICLE | Financial News

Intellia Therapeutics proposes IPO

April 18, 2016 7:00 AM UTC

Intellia Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Genomics, Cancer Date announced: 2016-04-11 Type: IPO To be raised: Up to $120 million Shares: TBD Price: TBD Underwriters: Cr...